Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.18
-0.36 (-2.51%)
At close: May 8, 2026, 4:00 PM EDT
14.14
-0.04 (-0.25%)
After-hours: May 8, 2026, 7:54 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $864.45 million as of May 8, 2026. Its market cap has decreased by -54.39% in one year.
Market Cap
864.45M
Enterprise Value
-70.36M
1-Year Change
-54.39%
Ranking
Category
Stock Price
$14.18
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $864.45M, an increase of 40.85%. That is a compound annual growth rate of 7.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 864.45M | 4.15% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 901.88M |
| Vor Biopharma | 901.11M |
| Absci | 896.93M |
| ARS Pharmaceuticals | 895.66M |
| CytomX Therapeutics | 871.86M |
| Bright Minds Biosciences | 867.50M |
| Theravance Biopharma | 866.48M |
| Alto Neuroscience | 865.10M |